Scarica l'app Stockscreener
10.69
4.47%
-0.50
Dopo l'orario di chiusura:
10.69
Trevi Therapeutics Inc Azioni (TRVI) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
1.41%
13.92
|
13.72 | 11.47 | 12.24 | 14.09 |
| Operating Income/Loss |
1.41%
-13.92
|
-13.72 | -11.47 | -12.24 | -14.09 |
| Nonoperating Income/Loss |
49.93%
2.099
|
1.40 | 1.119 | 0.844 | 0.814 |
| Income/Loss From Continuing Operations Before Tax |
4.10%
-11.82
|
-12.32 | -10.35 | -11.40 | -13.27 |
| Income Tax Expense/Benefit |
28.57%
-0.015
|
-0.021 | -0.011 | 0.016 | -0.031 |
| Income/Loss From Continuing Operations After Tax |
4.06%
-11.80
|
-12.30 | -10.34 | -11.41 | -13.24 |
|
Net Income/Loss
|
4.06%
-11.80
|
-12.30 | -10.34 | -11.41 | -13.24 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
11.32%
145.10
|
130.35 | 117.61 | 1.3558 | 101.28 |
| Diluted Average Shares |
11.32%
145.10
|
130.35 | 117.61 | 1.3558 | 101.28 |
| Basic Earnings Per Share |
11.11%
-0.08
|
-0.09 | -0.09 | -0.11 | -0.13 |
| Diluted Earnings Per Share |
11.11%
-0.08
|
-0.09 | -0.09 | -0.11 | -0.13 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):